← FDA Drug Approvals (Drugs@FDA)
EMPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ZYDUS PHARMS · Approved 2022-07-07
Drug application
- FDA Application #
ANDA212198- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- EMPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE
- Generic name
- Empagliflozin
- Active ingredients
- EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Discontinued
- Sponsor
- ZYDUS PHARMS
- First approval
- 2022-07-07
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown